RMC No. 42-2023: VAT-Exempt Medicines List Updated for FDA-Endorsed Products Under TRAIN and CREATE
RMC No. 42-2023 confirms FDA-endorsed updates to VAT-exempt medicines and applies exemption from FDA publication of the updated list. Pharmacies, hospitals, clinics, drug distributors, importers, and accounting teams dealing with medicines for cancer, diabetes, kidney disease, mental illness, tuberculosis, high cholesterol, and hypertension should immediately verify whether their products are covered by the FDA-endorsed updates […]